|
DCTN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.48240308917025E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.66599997633676E-09 |
| Normal-vs-Stage2 |
2.763800E-03 |
| Normal-vs-Stage3 |
4.0619000000075E-05 |
| Normal-vs-Stage4 |
2.649800E-02 |
| Stage1-vs-Stage2 |
4.253800E-01 |
| Stage1-vs-Stage3 |
3.354000E-01 |
| Stage1-vs-Stage4 |
4.937800E-01 |
| Stage2-vs-Stage3 |
1.474160E-01 |
| Stage2-vs-Stage4 |
3.371400E-01 |
| Stage3-vs-Stage4 |
9.561800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.61289919992691E-11 |
| Normal-vs-AfricanAmerican |
9.03690000608748E-09 |
| Normal-vs-Asian |
2.457400E-01 |
| Caucasian-vs-AfricanAmerican |
6.293400E-01 |
| Caucasian-vs-Asian |
6.557800E-01 |
| AfricanAmerican-vs-Asian |
5.119400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.45660200252019E-11 |
| Normal-vs-Female |
5.29760013634473E-10 |
| Male-vs-Female |
6.158400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.205800E-04 |
| Normal-vs-Extreme_Weight |
6.62759999991991E-07 |
| Normal-vs-Obese |
2.29149998975942E-09 |
| Normal-vs-Extreme_Obese |
1.391810E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.193400E-01 |
| Normal_Weight-vs-Obese |
1.388370E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.044200E-01 |
| Extreme_Weight-vs-Obese |
5.388800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.124000E-01 |
| Obese-vs-Extreme_Obese |
1.559440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.51199999999641E-05 |
| Normal-vs-Age(41-60Yrs) |
2.46610509790912E-11 |
| Normal-vs-Age(61-80Yrs) |
1.58359999558044E-08 |
| Normal-vs-Age(81-100Yrs) |
2.573600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.198200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.314000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.765700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.045000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.723400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.840200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.98077143365572E-13 |
| Normal-VS-Type2 PRCC |
3.52390000000202E-05 |
| Normal-VS-KIRP CIMP |
3.442900E-04 |
| Normal-VS-Unclassified PRCC |
1.50506999999633E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.355800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.951000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.120600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.340800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.406230E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.544000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.186700E-04 |
| Normal-vs-N1 |
3.026400E-04 |
| Normal-vs-N2 |
3.93120000000691E-05 |
| N0-vs-N1 |
4.016400E-01 |
| N0-vs-N2 |
2.170600E-01 |
| N1-vs-N2 |
3.857800E-01 |
|
|
